株式会社トランスジェニック 事業計画及び成長可能性に関する説明資料

This document is an explanatory material regarding the business plan and growth potential of TransGenic Inc., created on May 25, 2022. It includes company overview, business model, market environment, growth strategy, and risk information. TransGenic aims for sustainable growth through its drug discovery support business and succession-type M&A, utilizing cutting-edge biotechnology. The company provides a range of drug discovery support services, including preclinical and clinical trials, tailored to customer needs. The growth strategy emphasizes rapid adaptation to changes in the business environment and strengthening the revenue base.